StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.72+0.24 (+5.36%)

Close on Nov 18, 2026Market cap $969.77MP/E –Yield –

Savara price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Savara's price to sales ratio was 400.4× on Apr 30, 2021, against 310.4× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Apr 30, 2021400.4×+157.2
2020Dec 31, 2020243.2×+204.5
2017Jul 31, 201738.7×−165.4
2016Dec 30, 2016204.1×–

More Savara figures

See a number that looks wrong?